Sector: Professional, Scientific, and Technical Services Industry: Research and Development in Biotechnology
9.69
0.2
(2.107%)
Volume:
1,028,305
52 week range:
7.72 - 31.55
Market Cap:
1.304B
Company Description:
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.